局部麻醉下经会阴自由手多参数磁共振融合靶向穿刺的疼痛结局与预测因素:1008例多中心研究
该多中心前瞻性研究纳入1008例在局部麻醉下接受多参数磁共振-经会阴融合穿刺(靶向+系统穿刺)的男性,评估疼痛评分及重度疼痛相关因素。结果显示麻醉给药时疼痛评分为3.9±2.1,穿刺时为3.1±2.3,疼痛不影响临床显著前列腺癌靶向检出,年龄为保护因素而严重焦虑和手术时间增加重度疼痛风险。
要点
- 局部麻醉下经会阴融合穿刺疼痛程度中等,穿刺时平均评分3.1±2.3。
- 疼痛不降低临床显著前列腺癌靶向穿刺检出率(p=0.23和p=0.47)。
- 严重焦虑(OR 2.99)和较长手术时间(OR 1.04)增加重度穿刺疼痛风险。
核心结论
- 局部麻醉下经会阴融合穿刺引起中等程度疼痛,且疼痛不影响临床显著前列腺癌靶向检出。
- 患者焦虑可预测穿刺疼痛,基于数值评定量表的焦虑评估可用于识别重度疼痛高风险者。
研究设计与样本
- 2016至2019年多中心前瞻性研究,纳入1008例在局部麻醉下接受多参数磁共振-经会阴融合穿刺(靶向+系统穿刺)的男性。
主要发现
- 局部麻醉给药时疼痛数值评定量表评分为3.9±2.1,穿刺时为3.1±2.3。
- 疼痛与靶向穿刺临床显著前列腺癌检出降低无关(p=0.23和p=0.47,取决于临床显著前列腺癌定义)。
- 多因素分析显示年龄为重度穿刺疼痛的保护因素(OR 0.96,95%CI 0.94-0.99)。
- 严重焦虑为重度穿刺疼痛的危险因素(OR 2.99,95%CI 1.83-4.89)。
- 手术时间与重度穿刺疼痛风险增加相关(OR 1.04,95%CI 1.00-1.08)。
关键数值与推荐
- 若测试焦虑预防措施对疼痛的可能效果,以数值评定量表焦虑评分大于6为界,可使接受治疗的患者数降至13%,同时识别出56%的重度疼痛患者。
临床怎么用
- 局部麻醉下经会阴融合穿刺疼痛可接受,无需因担心疼痛影响检出而改变策略。
- 术前可用数值评定量表评估焦虑,对焦虑评分高者考虑预防性措施以降低重度疼痛风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Several transperineal biopsy series have proven feasibility under local anesthesia. However, there is a lack of large analyses detailing pain outcomes and factors influencing pain. MATERIALS AND METHODS: From 2016 to 2019 we performed a multicenter prospective study in men undergoing multiparametric magnetic resonance imaging-transperineal fusion biopsies (target+systematic cores) under local anesthesia. Primary outcomes were 1) pain scores (assessed through a 0 to 10-point numeric rating scale) and 2) identification of factors associated with severe pain. The secondary outcome was to evaluate pain influence on clinically significant prostate cancer target cores detection. RESULTS: We included 1,008 men undergoing transperineal fusion biopsies under local anesthesia. Mean±SD numeric rating scale pain scores were 3.9±2.1 at local anesthesia administration and 3.1±2.3 when performing biopsies. Pain was not associated with lower clinically significant prostate cancer detection on targeted cores (p=0.23 and p=0.47 depending on clinically significant prostate cancer definition). On multivariate analysis age (OR 0.96, 95% CI 0.94-0.99) and severe anxiety (OR 2.99, 95% CI 1.83-4.89) were a protective and risk factor, respectively, for severe biopsy pain. Procedural time was also associated with an increased risk of experiencing severe biopsy pain (OR 1.04, 95% CI 1.00-1.08). If aiming to test the possible effects of anxiety preventive measures on pain, an anxiety cutoff greater than 6 on a numeric rating scale would decrease to 13% the number of patients being treated while identifying 56% of those experiencing severe pain. CONCLUSIONS: Transperineal fusion biopsies under local anesthesia result in moderate pain. Pain does not influence clinically significant prostate cancer target detection. Patient anxiety predicts pain. A numeric rating scale based anxiety assessment may be used to identify those at higher risk for experiencing severe pain in men undergoing transperineal fusion biopsies.
引用
- Marra G, Zhuang J, Marquis A, et al. Pain in Men Undergoing Transperineal Free-Hand Multiparametric Magnetic Resonance Imaging Fusion Targeted Biopsies under Local Anesthesia: Outcomes and Predictors from a Multicenter Study of 1,008 Patients. J Urol. 2020. PMID: 32628099. doi:10.1097/JU.0000000000001234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。